KERATOCONJUNCTIVITIS SICCA
Clinical trials for KERATOCONJUNCTIVITIS SICCA explained in plain language.
Never miss a new study
Get alerted when new KERATOCONJUNCTIVITIS SICCA trials appear
Sign up with your email to follow new studies for KERATOCONJUNCTIVITIS SICCA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drops aim to soothe dry eye sufferers
Symptom relief CompletedThis Phase 3 trial tested rebamipide eye drops in 762 people with dry eye lasting at least 6 months. Participants received either rebamipide or placebo drops for 26 weeks. The goal was to see if the drops could reduce eye surface damage and discomfort better than placebo.
Matched conditions: KERATOCONJUNCTIVITIS SICCA
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New eye drops aim to soothe dry eye sufferers
Symptom relief CompletedThis Phase 3 trial tested rebamipide eye drops in 755 people with dry eye for at least 6 months. Participants received either rebamipide or placebo drops for up to 52 weeks. The goal was to see if the drops could reduce eye surface damage and ease discomfort.
Matched conditions: KERATOCONJUNCTIVITIS SICCA
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New eye drops aim to soothe dry eyes with fewer doses
Symptom relief CompletedThis completed study tested whether Reinnerva/Lubristil+G eye drops work better than Vismed for people with dry eyes. Forty adults with dry eye symptoms used one drop in each eye twice daily (Reinnerva/Lubristil+G) or four times daily (Vismed) for 60 days. Researchers measured te…
Matched conditions: KERATOCONJUNCTIVITIS SICCA
Phase: NA • Sponsor: Medivis SRL • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Can a common supplement soothe Sjogren's dry eye?
Symptom relief CompletedThis small study tested whether levocarnitine, a natural substance, can help treat dry eye in adults with Sjogren's syndrome. Fifteen participants received both the drug and a placebo in a crossover design. The goal was to see if levocarnitine reduces eye inflammation and improve…
Matched conditions: KERATOCONJUNCTIVITIS SICCA
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC